Xeris Biopharma Reports Second Quarter 2024 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/11/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. TLT
9. PMTS
10. QQQ

Go back to Xeris Biopharma Reports Second Quarter 2024 Financial Results
(NASDAQ: XERS) Delayed: 7.45 -0.22 (2.87%)
Previous Close $7.67    52 Week High $ 
Open $7.89    52 Week Low $ 
Day High $7.89    P/E N/A 
Day Low $7.40    EPS $ 
Volume 3,208,553